Cargando…
Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
Since Isaac's and Lindenmann's seminal experiments over 50 years ago demonstrating a soluble factor generated from heat killed virus-stimulated chicken embryos could inhibit live influenza virus replication, the term interferon has been synonymous with inhibition of virus replication. Whil...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112115/ https://www.ncbi.nlm.nih.gov/pubmed/27769506 http://dx.doi.org/10.1016/bs.ai.2016.08.001 |
_version_ | 1783513421042417664 |
---|---|
author | Teijaro, J.R. |
author_facet | Teijaro, J.R. |
author_sort | Teijaro, J.R. |
collection | PubMed |
description | Since Isaac's and Lindenmann's seminal experiments over 50 years ago demonstrating a soluble factor generated from heat killed virus-stimulated chicken embryos could inhibit live influenza virus replication, the term interferon has been synonymous with inhibition of virus replication. While the antiviral properties of type 1 interferon (IFN-I) are undeniable, recent studies have reported expanding and somewhat unexpected roles of IFN-I signaling during both acute and persistent viral infections. IFN-I signaling can promote morbidity and mortality through induction of aberrant inflammatory responses and recruitment of inflammatory innate immune cell populations during acute respiratory viral infections. During persistent viral infection, IFN-I signaling promotes containment of early viral replication/dissemination, however, also initiates and maintains immune suppression, lymphoid tissue disorganization, and CD4 T cell dysfunction through modulation of multiple immune cell populations. Finally, new data are emerging illuminating how specific IFN-I species regulate immune pathology and suppression during acute and persistent viral infections, respectively. Systematic characterization of the cellular populations that produce IFN-I, how the timing of IFN-I induction and intricacies of subtype specific IFN-I signaling promote pathology or immune suppression during acute and persistent viral infections should inform the development of treatments and modalities to control viral associated pathologies. |
format | Online Article Text |
id | pubmed-7112115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71121152020-04-02 Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses Teijaro, J.R. Adv Immunol Article Since Isaac's and Lindenmann's seminal experiments over 50 years ago demonstrating a soluble factor generated from heat killed virus-stimulated chicken embryos could inhibit live influenza virus replication, the term interferon has been synonymous with inhibition of virus replication. While the antiviral properties of type 1 interferon (IFN-I) are undeniable, recent studies have reported expanding and somewhat unexpected roles of IFN-I signaling during both acute and persistent viral infections. IFN-I signaling can promote morbidity and mortality through induction of aberrant inflammatory responses and recruitment of inflammatory innate immune cell populations during acute respiratory viral infections. During persistent viral infection, IFN-I signaling promotes containment of early viral replication/dissemination, however, also initiates and maintains immune suppression, lymphoid tissue disorganization, and CD4 T cell dysfunction through modulation of multiple immune cell populations. Finally, new data are emerging illuminating how specific IFN-I species regulate immune pathology and suppression during acute and persistent viral infections, respectively. Systematic characterization of the cellular populations that produce IFN-I, how the timing of IFN-I induction and intricacies of subtype specific IFN-I signaling promote pathology or immune suppression during acute and persistent viral infections should inform the development of treatments and modalities to control viral associated pathologies. Elsevier Inc. 2016 2016-09-20 /pmc/articles/PMC7112115/ /pubmed/27769506 http://dx.doi.org/10.1016/bs.ai.2016.08.001 Text en Copyright © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Teijaro, J.R. Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses |
title | Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses |
title_full | Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses |
title_fullStr | Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses |
title_full_unstemmed | Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses |
title_short | Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses |
title_sort | pleiotropic roles of type 1 interferons in antiviral immune responses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112115/ https://www.ncbi.nlm.nih.gov/pubmed/27769506 http://dx.doi.org/10.1016/bs.ai.2016.08.001 |
work_keys_str_mv | AT teijarojr pleiotropicrolesoftype1interferonsinantiviralimmuneresponses |